Missing/wrong data?
Log in to edit
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.
scientific article
Author/s
author: Philip W. Kantoff, Florence Raynaud, Eric J Small
Work details
Publication date
February 16, 2010
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.